NASDAQ:STRF 25 September 2025

Strategy’s Bitcoin Bonanza: Stock Doubles, $10B Profit & Bold 2025 Forecast

Strategy Inc.’s Q2 2025 net income hit a record $10.0 billion, fueled by a $14 billion unrealized gain on its 639,835 Bitcoin holdings. The stock is up 106% year-over-year but fell nearly 20% this quarter. The company raised $10.5 billion in new capital this year, expanding its Bitcoin stash but diluting shares. Executives project $24 billion in 2025 net income if Bitcoin reaches $150,000 by year-end.

25 September 2025

Bitcoin·Cryptocurrency·Financial Forecasts·NASDAQ:STRC·NASDAQ:STRD·NASDAQ:STRF·NASDAQ:STRK·Stock Market

Arvinas (ARVN) Shares Surge 6.9% on Positive Parkinson's Drug Data
April 2, 2026, 4:43 AM EDT. Arvinas Inc (ARVN) shares jumped 6.9% to close at $11.33, supported by higher than normal trading volume. The increase follows promising clinical data from its experimental drug ARV-102 targeting LRRK2, a protein linked to Parkinson's disease. Early-stage results showed a 50% or greater reduction of LRRK2 protein in cerebrospinal fluid by day 14, sustained through day 28. Despite this optimism, Arvinas is expected to report a quarterly loss of $0.94 per share, a 182.5% year-over-year decline, with revenues forecasted down 91%. Earnings estimate revisions for the quarter have trended slightly downward, commonly a bearish signal for stock price. The stock holds a Zacks Rank #3 (Hold), reflecting cautious investor sentiment amid mixed fundamentals and promising pipeline developments.